Morning After The Morning's Trash

In my last post , I focused on flaws in the medical device approval process. The Union of Concerned Scientists FDA at a Crossroads meeting also covered problems with drug approval. This is perhaps no better illustrated than by the disappointing decision by Secretary of Health Kathleen Sebelius to deny the emergency contraceptive, Plan B, over-the-counter status for women under the age of 17 . This was a particular disappointment to many because President Obama had promised that decisions at the FDA would be made based on science, rather than politics. Some of us, naively, hoped that change we can believe in was real, having forgotten that the Tooth Fairy wasn t.